Skip to main content
    C

    Cardio Diagnostics Holdings Inc (CDIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.79
    -0.10 (-5.29%)

    Market Cap: $5.59M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Cardio Diagnostics Holdings Inc (CDIO) Financials: Revenue, Profit and Cash Flow

    Updated Nov 6, 2026. Financial statements from company filings, amounts in US dollars.

    Cardio Diagnostics Holdings reported revenue of $14.82K for the fiscal year ended Dec 31, 2025, down 57.5% from the year before. That year, net income was -$6.50M with a net margin of -43832.5%, operating cash flow was -$5.73M and free cash flow was -$5.91M. The quarter ended Sep 30, 2026 had revenue of $3.59K and net income of -$1.73M.

    Revenue and Margins

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$14.82K-57.5%100.0%-43737.5%-43832.5%
    Dec 2024$34.89K+104.5%100.0%-23977.9%-24028.2%
    Dec 2023$17.07K+1696.3%100.0%-42440.4%-49087.8%
    Dec 2022$950+5.4%100.0%-478784.3%-490630.0%
    Dec 2021$901N/A100.0%-68862.2%-68862.2%
    Dec 2020$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2020 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Revenue$14.82K$34.89K$17.07K$950$901$0
    Gross profit$14.82K$34.89K$17.07K$950$901N/A
    Research and development$641.21K$227.97K$145.18K$40.45K$31.47K$1.50K
    Operating income-$6.48M-$8.37M-$7.24M-$4.55M-$620.45K-$609.16K
    Net income-$6.50M-$8.38M-$8.38M-$4.66M-$620.45K-$605.16K
    EBITDA-$6.10M-$8.11M-$1.72MN/A-$604.45K-$598.50K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$3.59K$5.36K$2.68K$3.56K$2.85K$7.47K$940$4.51K$6.58K$7.87K$15.93K$5.31K
    Gross profit$3.59K$5.36K$2.68K$3.56K$2.85K$7.47K$940$4.51K$6.58K$7.87K$15.93K$5.31K
    Operating income-$1.73M-$1.50M-$1.78M-$1.46M-$1.71M-$1.68M-$1.63M-$1.52M-$1.41M-$1.28M-$4.16M-$1.54M
    Net income-$1.73M-$1.50M-$1.79M-$1.47M-$1.71M-$1.68M-$1.64M-$1.52M-$1.41M-$1.29M-$4.16M-$1.39M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $507.40K by $4.60M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Total assets$7.77M$10.62M$4.46M$6.25M$1.10M$446.38K
    Current assets$5.92M$8.79M$2.77M$5.89M$803.51K$245.92K
    Cash and equivalents$5.11M$7.83M$1.28M$4.12M$512.77K$237.09K
    Total liabilities$793.06K$1.06M$1.50M$1.95M$33.88K$386.01K
    Short-term debt$507.40K$544.03K$597.93K$849.03KN/AN/A
    Shareholder equity$6.97M$9.56M$2.96M$4.30M$1.07M$60.37K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$6.08M$7.93M$9.56M$7.77M$8.79M$10.40M$12.28M$10.62M$4.48M$4.00M$4.33M$4.46M
    Total liabilities$366.00K$499.78K$655.97K$793.06K$637.33K$671.85K$905.00K$1.06M$795.28K$922.53K$1.29M$1.50M
    Cash and equivalents$3.94M$5.59M$7.08M$5.11M$6.36M$7.97M$9.69M$7.83M$1.98M$1.31M$1.56M$1.28M
    Shareholder equity$5.72M$7.43M$8.90M$6.97M$8.15M$9.72M$11.38M$9.56M$3.69M$3.07M$3.04M$2.96M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Operating cash flow-$5.73M-$4.99M-$5.67M-$5.09M-$585.29K$25.86K
    Capital expenditures$187.32K$214.76K$575.66K$0$114.03K$29.91K
    Free cash flow-$5.91M-$5.21M-$6.25M-$5.09M-$699.32K-$4.05K
    Investing cash flow-$419.31K-$404.19K-$794.29K-$368.00K-$364.03K-$29.91K
    Financing cash flow$3.43M$11.94M$3.63M$9.06M$1.23M$240.00K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$1.52M-$1.34M-$1.56M-$1.36M-$1.39M-$1.57M-$1.40M-$1.39M-$1.16M-$1.21M-$1.23M-$1.69M
    Capital expendituresN/AN/A$1.76K$17.02K$162.83K$18.70K$5.79K$3.64K$23.25K$167.90K$19.98K$537.05K
    Free cash flowN/AN/A-$1.56M-$1.38M-$1.56M-$1.59M-$1.41M-$1.40M-$1.18M-$1.38M-$1.25M-$2.22M
    Last 12 quarters

    Frequently Asked Questions About CDIO

    What is Cardio Diagnostics Holdings' annual revenue?

    Cardio Diagnostics Holdings reported revenue of $14.82K for the fiscal year ended Dec 31, 2025.

    How fast is Cardio Diagnostics Holdings' revenue growing?

    Revenue was down 57.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 149.9%.

    Is Cardio Diagnostics Holdings profitable?

    No. Cardio Diagnostics Holdings reported net income of -$6.50M for the fiscal year ended Dec 31, 2025, with a net margin of -43832.5%.

    How much free cash flow does CDIO generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$5.73M minus capital expenditures of $187.32K produced free cash flow of -$5.91M.

    How much debt does Cardio Diagnostics Holdings have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $507.40K and cash and equivalents of $5.11M.